Patient Recruitment for Phase IB Tobacco Research Study

February 9, 2018

How We’ve Helped - Media and EAs

Challenge

Our customer, a top-tier CRO, had been running their study for six months when enrollment, as well as new screenings, had plateaued. While we’ve executed dozens of successful recruitment programs for this customer in the past, they were hesitant to bring us on board to rescue the program because we had no previous related experience with this very unique type of study/ patient population.

Solution

After lengthy consideration and no increase in new screenings or enrollments, they knew that they needed to do something, and contracted with us to conduct a pilot. We very quickly built their confidence by showing results from the pilot, and expanded by utilizing strategic media buys, including radio, TV, and print, across 13 sites and 8 markets, to jump start screening and enrollment. Additionally, we provided site materials kits and a study website with on-line self-screener as an informational tool, available 24/7. We also provided in-field “on-the-ground” support through our Enrollment Assistant™ services at select sites.

Results

ThreeWire screened a total of 3,650 patients in just a little over six months, referred 1,451 patients, netting a total of 71 (ThreeWire) enrollments, allowing the CRO and sponsor to close enrollment ahead of their adjusted enrollment timeline.

“Unlike many other patient recruitment companies, ThreeWire truly delivers on their projections… they are adept at placing media in the most targeted and efficient manner to deliver high quality referrals to the site.”
- Case Study Recruitment Lead Top 10 Pharma Company

 

Previous Flipbook
Patient Recruitment for Multi-Protocol Global Program (Phase III Cardiovascular Disease)
Patient Recruitment for Multi-Protocol Global Program (Phase III Cardiovascular Disease)

Our customer needed support for a global, multi-protocol program which was behind with enrollment.

Next Flipbook
Patient Recruitment for Phase II Dermatology Study in US & Europe
Patient Recruitment for Phase II Dermatology Study in US & Europe

Enrollment for this 100-patient study had been underway for 11 months across 32 sites globally, yet only 20...